Omadacycline therapy for Mycobacterium abscessus species infections.
Sign Up to like & getrecommendations! Published in 2023 at "Internal medicine journal"
DOI: 10.1111/imj.16071
Abstract: BACKGROUND Antimicrobial resistance and therapy related adverse effects make Mycobacterium abscessus treatment challenging. Omadacycline is a novel, bioavailable aminomethylcycline with favourable in-vitro activity against M. abscessus. AIMS To describe a case report and review the… read more here.
Keywords: abscessus species; mycobacterium abscessus; therapy; therapy mycobacterium ... See more keywords